Profile

Giuseppe Orlando, M.D., Ph.D.Wake Forest Baptist Health

Doctor Rating

4.7 out of 5

60 Ratings
1 Comments
 

Giuseppe Orlando, M.D., Ph.D.

Assistant Professor, Surgical Sciences-Transplant

Clinical Interests

Transplant Urology, Kidney Transplantation, Pancreas Transplantation, Transplant Immunology, Transplant Immunosuppression, Transplant Surgery

Contact Information

New Patient Appointments: 336-716-WAKE
Returning Patient Appointments: 336-716-0548
Department: 336-716-2011

Email: gorlando@wakehealth.edu

Insurance Accepted »

Additional Languages

French, Italian

Related Links

Education & Training

  • M.D., Tor Vergata Medical School, 1996
  • Ph.D., Tor Vergata Medical School, 2006
  • Fellowship, Marie Curie Internat'l, 2011

Memberships

  • Italian Society of Organ Trans
  • Am Soc Of Transplant Surgeons
  • Euro Soc Organ Transplant

NPI Number

  • 1821380650
Giuseppe Orlando, M.D., Ph.D.

Doctor Rating

4.7 out of 5

60 Ratings
1 Comments
 

Giuseppe Orlando, M.D., Ph.D.

Assistant Professor, Surgical Sciences-Transplant

Research Interests

Regenerative Medicine; Liver Transplantation; Organ Transplantation; Kidney Transplantation; Tissue Engineering
More »

Contact Information

Academic: 336-716-6903 | Department: 336-716-2011

Email: gorlando@wakehealth.edu

Related Links

Recent Publications

Bioengineering functional human sphincteric and non-sphincteric gastrointestinal smooth muscle constructs. Rego SL, Zakhem E, Orlando G, Bitar KN.. Methods. 2016;99():128-134.

The efficacy and safety of mammalian target of rapamycin inhibitors ab initio after liver transplantation without corticosteroids or induction therapy. Manzia TM, Angelico R, Toti L, Belardi C, Cillis A, Quaranta C, Tariciotti L, Katari R, Mogul A, Sforza D, Orlando G, Tisone G.. Dig Liver Dis. 2016;48(3):315-320.

Decellularized renal matrix and regenerative medicine of the kidney: a different point of view. Petrosyan A, Zanusso I, Lavarreda-Pearce M, Leslie S, Sedrakyan S, De Filippo RE, Orlando G, Da Sacco S, Perin L.. Tissue Eng Part B Rev. 2016;22(3):183-192.

Kidney transplantation, bioengineering and regeneration: an originally immunology-based discipline destined to transition towards ad hoc organ manufacturing and repair. Rogers J, Katari R, Gifford S, Tamburrini R, Edgar L, Voigt MR, Murphy SV, Igel D, Mancone S, Callese T, Colucci N, Mirzazadeh M, Peloso A, Zambon JP, Farney AC, Stratta RJ, Orlando G.. Expert Rev Clin Immunol. 2016;12(2):169-182.

The human pancreas as a source of protolerogenic extracellular matrix scaffold for a new-generation bioartificial endocrine pancreas. Peloso A, Urbani L, Cravedi P, Katari R, Maghsoudlou P, Fallas ME, Sordi V, Citro A, Purroy C, Niu G, McQuilling JP, Sittadjody S, Farney AC, Iskandar SS, Zambon JP, Rogers J, Stratta RJ, Opara EC, Piemonti L, Furdui CM, Soker S, De Coppi P, Orlando G.. Ann Surg. 2016;264(1):169-179.

Bioengineered human pyloric sphincters using autologous smooth muscle and neural progenitor cells. Rego SL, Zakhem E, Orlando G, Bitar KN.. Tissue Eng Part A. 2016;22(1-2):151-160.

APOL1 genotype and kidney transplantation outcomes from deceased African American donors. Freedman BI, Pastan SO, Israni AK, Schladt D, Julian BA, Gautreaux MD, Hauptfeld V, Bray RA, Gebel HM, Kirk AD, Gaston RS, Rogers J, Farney AC, Orlando G, Stratta RJ, Mohan S, Ma L, Langefeld CD, Bowden DW, Hicks PJ, Palmer ND,.. Transplantation. 2016;100(1):194-202.

The DESCARTES-Nantes survey of kidney transplant recipients displaying clinical operational tolerance identifies 35 new tolerant patients and 34 almost tolerant patients. Massart A, Pallier A, Pascual J, Viklicky O, Budde K, Spasovski G, Klinger M, Sever MS, Sorensen SS, Hadaya K, Oberbauer R, Dudley C, De Fijter JW, Yussim A, Hazzan M, Wekerle T, Berglund D, De Biase C, Perez-Saez MJ, Muhlfeld A, Orlando G,.. Nephrol Dial Transplant. 2016;31(6):1002-1013.

Is prolonged cold ischemia a contraindication to using kidneys from acute kidney injury donors? [abstract]. Carrier A, Kahn MA, El-Hennawy H, Farney A, Rogers J, Orlando G, Stratta R.. Am J Transplant. 2016;16(Suppl 1):43.

Eversion endarterectomy of the deceased donor renal artery to prevent kidney discard [abstract]. Jones K, Khan A, El-Hennawy H, Farney A, Rogers J, Orlando G, Stratta R.. Am J Transplant. 2016;16(Suppl 1):44.

Differential effect of delayed graft function on kidney transplant outcomes [abstract]. Khan M, El-Hennawy H, Farney A, Rogers J, Orlando G, Brim E, Hairston G, Mangus M, Stratta R.. Am J Transplant. 2016;16(Suppl 1):53.

Analysis of local versus imported expanded criteria donor (ECD) kidneys: a single center experience with 497 ECD kidney transplants [abstract]. Khan M, El-Hennawy H, Rogers J, Farney A, Orlando G, Palanisamy A, Reeves-Daniel A, Stratta R.. Am J Transplant. 2016;16(Suppl 1):54.

Dual kidney transplants from adult marginal donors successfully expand the limited deceased donor organ pool. Stratta RJ, Farney AC, Orlando G, Farooq U, Al-Shraideh Y, Palanisamy A, Reeves-Daniel A, Doares W, Kaczmorski S, Gautreaux MD, Iskandar SS, Hairston G, Brim E, Mangus M, El-Hennawy H, Khan M, Rogers J.. Clin Transplant. 2016;30(4):380-392.

Single vs dual (en bloc) kidney transplants from donors less than or equal to 5 years of age: a single center experience. Al-Shraideh Y, Farooq U, El-Hennawy H, Farney AC, Palanisamy A, Rogers J, Orlando G, Khan M, Reeves-Daniel A, Doares W, Kaczmorski S, Gautreaux MD, Iskandar SS, Hairston G, Brim E, Mangus M, Stratta RJ.. World J Transplant. 2016;6(1):239-248.

Role of allograft nephrectomy following kidney graft failure: preliminary experience with pre-operative angiographic kidney embolization. Al-Geizawi SM, Singh RP, Zuckerman JM, Requarth JA, Farney AC, Rogers J, Taussig J, Orlando G, Stratta RJ.. J Nephrol. 2015;28(3):379-385.

One-shot versus multidose perioperative antibiotic prophylaxis after kidney transplantation: a randomized, controlled clinical trial. Orlando G, Manzia TM, Sorge R, Iaria G, Angelico R, Sforza D, Toti L, Peloso A, Patel T, Katari R, Zambon JP, Maida A, Salerno MP, Clemente K, Di Cocco P, De Luca L, Tariciotti L, Famulari A, Citterio F, Tisone G, Pisani F, Romagnoli J.. Surgery. 2015;157(1):104-110.

Abdominal organ bioengineering: current status and future perspectives. Peloso A, Katari R, Zambon JP, Defrancesco A, Moore A, Holton C, Mogul A, Manzia TM, Orlando G.. Minerva Chir. 2015;70(1):43-55.

Simultaneous transplantation of the living donor kidney and deceased donor pancreas and other transplant options for diabetic and uremic patients. Farney AC, Rogers J, Orlando G, Stratta RJ.. Curr Opin Organ Transplant. 2015;20(1):103-107.

Tissue engineering and regenerative medicine: semantic considerations for an evolving paradigm. Katari R, Peloso A, Orlando G.. Front Bioeng Biotechnol. 2015;2():57.

Does prolonged cold ischemia influence outcomes following pancreas transplantation? [abstract]. El Hennawy H, Rogers J, Farney A, Orlando G, Kahn M, Reeves-Daniel A, Palanisamy A, Stratta R.. Am J Transplant. 2015;15(Suppl 1):112.

Analysis of local versus imported expanded criteria donor (ECD) kidneys: a single center experience with 497 ECD kidney transplants [abstract]. El Hennawy H, Farney A, Orlando G, Rogers J, Khan M, Reeves-Daniel A, Palanisamy A, Gautreaux M, Iskandar S, Doares W, Kaczmorski S, Mangus M, Stratta R.. Am J Transplant. 2015;15(Suppl 1):75.

Prospect for kidney bioengineering: shortcomings of the status quo. Peloso A, Katari R, Murphy SV, Zambon JP, DeFrancesco A, Farney AC, Rogers J, Stratta RJ, Manzia TM, Orlando G.. Expert Opin Biol Ther. 2015;15(4):547-558.

Discarded human pancreas as source of ECM scaffold for a new generation bio-artificial endocrine pancreas [abstract]. Peloso A, Katari R, Urbani L, Maghsoudlou P, Fallas MEA, Citro A, Delario G, Willis C, Farney A, Rogers J, Stratta R, Peimonti L, Soker S, Orlando G.. Am J Transplant. 2015;15(Suppl 1):49.

Pancreas transplantation in C-peptide positive patients: does 'type' of diabetes really matter?. Stratta RJ, Rogers J, Farney AC, Orlando G, El-Hennawy H, Gautreaux MD, Reeves-Daniel A, Palanisamy A, Iskandar SS, Bodner JK.. J Am Coll Cardiol. 2015;220(4):716-727.

Apolipoprotein L1 gene variants in deceased organ donors are associated with renal allograft failure. Freedman BI, Julian BA, Pastan SO, Israni AK, Schladt D, Gautreaux MD, Hauptfeld V, Bray RA, Gebel HM, Kirk AD, Gaston RS, Rogers J, Farney AC, Orlando G, Stratta RJ, Mohan S, Ma L, Langefeld CD, Hicks PJ, Palmer ND, Adams PL,.. Am J Transplant. 2015;15(6):1615-1622.

Semi-xenotransplantation: the regenerative medicine-based approach to immunosuppression-free transplantation and to meet the organ demand. Salvatori M, Peloso A, Katari R, Soker S, Lerut JP, Stratta RJ, Orlando G.. Xenotransplantation. 2015;22(1):1-6.

Deceased donor multidrug resistance protein 1 and caveolin 1 gene variants may influence allograft survival in kidney transplantation. Ma J, Divers J, Palmer ND, Julian BA, Israni AK, Schladt D, Pastan SO, Chattrabhuti K, Gautreaux MD, Hauptfeld V, Bray RA, Kirk AD, Brown WM, Gaston RS, Rogers J, Farney AC, Orlando G, Stratta RJ, Guan M, Palanisamy A, Reeves-Daniel AM, Bowden DW,.. Kidney Int. 2015;88(3):584-592.

Donor-derived myeloid sarcoma in two kidney transplant recipients from a single donor. Palanisamy A, Persad P, Koty PP, Douglas LL, Stratta RJ, Rogers J, Reeves-Daniel AM, Orlando G, Farney AC, Beaty MW, Pettenati MJ, Iskandar SS, Grier DD, Kaczmorski SA, Doares WH, Gautreaux MD, Freedman BI, Powell BL.. Case Rep Nephrol. 2015;2015():821346.

Human pyloric sphincters bioengineered using autologous pyloric smooth muscle cells and neural progenitor cells [abstract]. Rego SL, Zakhem E, Orlando G, Bitar KN.. Gastroenterology. 2015;148(4 Suppl 1):S-116-117.

Successful implantation of an engineered tubular neuromuscular tissue composed of human cells and chitosan scaffold. Zakhem E, Elbahrawy M, Orlando G, Bitar KN.. Surgery. 2015;158(6):1598-1608.

Current achievements and future perspectives in whole-organ bioengineering. Peloso A, Dhal A, Zambon JP, Li P, Orlando G, Atala A, Soker S.. Stem Cell Res Ther. 2015;6():107.

Renal extracellular matrix scaffolds from discarded kidneys maintain glomerular morphometry and vascular resilience and retains critical growth factors. Peloso A, Petrosyan A, Da Sacco S, Booth C, Zambon JP, O'Brien T, Aardema C, Robertson J, De Filippo RE, Soker S, Stratta RJ, Perin L, Orlando G.. Transplantation. 2015;99(9):1807-1816.

Serum antiphospholipid antibodies in transplanted patients: potential follow-up markers to assess pregnancy risk?. Ortona E, Colasanti T, Derme M, Iannini I, Vomero M, Sorice M, D'Alessandro F, Costa AN, Malorni W, Orlando G, Framarino-Dei-Malatesta M.. Transplantation. 2015;99(9):e152-e154.

Tissue-engineering approaches to restore kidney function. Katari R, Edgar L, Wong T, Boey A, Mancone S, Igel D, Callese T, Voigt M, Tamburrini R, Zambon JP, Perin L, Orlando G.. Curr Diab Rep. 2015;15(10):69.

Renal ECM scaffolds from discarded kidneys are bioactive, pro-tolerogenic, cyto-compatible and feature an intact, patent and resilient vascular feature an intact, patent and resilient vasculature [abstract]. Orlando G, Pelso A, Petrosyan A, Da Sacco S, Cravedi P, Zambon J, Soker S, DeFilippo RE, Stratta R, Perin L.. Tissue Eng Part A. 2015;21(Suppl 1):S103-S104.

Development of techniques for pancreatic beta-cell engineering [abstract]. Niu G, McQuilling J, Peloso A, Opara EC, Orlando G, Soker S.. Tissue Eng Part A. 2015;21(Suppl 1):S289.

The human pancreas as a source of pro-tolerogenic extracellular matrix scaffold for a new generation bio-artificial endocrine pancreas [abstract]. Peloso A, Orlando G, Urbani L, Cravedi P, Sordi V, Guoguang N, Citro A, Mcquilling J, Farney A, Iskandar S, Rogers J, Stratta R, Opara E, Piemonti L, Soker S, De Coppi P, Petrosyan A.. Tissue Eng Part A. 2015;21(Suppl 1):S141.

Recycling organs - growing tailor-made replacement kidneys [editorial]. Gifford S, Zambon JP, Orlando G.. Regen Med. 2015;10(8):913-915.

Tissue engineering human kidneys for costimulatory blockade [abstract]. Brasile L, Henry N, Orlando G, Stubenitsky B.. Transpl Int. 2015;28(Suppl 4):15.

Proposal for a predictive score of de novo donor-specific antibody development following kidney transplantation [abstract]. Lai Q, Papola F, Cervelli C, Orlando G, Di Pietro V, De Luca L, Clemente K, Iesari S, Famulari A, Pisani F.. Transpl Int. 2015;28(Suppl 4):533.

Renal ECM scaffolds from discarded kidneys are bioactive, pro-tolerogenic, cyto-compatible and feature an intact, patient and resilient vascular feature an intact, patent and resilient vasculature [abstract]. Orlando G, Peloso A, Petrosyan A, Da Sacco S, Cravedi P, Zambon JP, O'Brien T, Aardema C, Robertson J, De Filippo RE, Soker S, Stratta RJ, Laura P.. Transpl Int. 2015;28(Suppl 4):15-16.

One-shot versus multidose perioperative antibiotic prophylaxis after kidney transplantation: a randomized, controlled, clinical trial [abstract]. Orlando G, Manzia TM, Sorge R, Iaria G, Angelico R, Sforza D, Toti L, Peloso A, Patel T, Katari R, Zambon JP, Maida A, Salerno MP, Clemente K, Di Cocco PP, De Linda L, Tariciotti L, Antonio F, Citterio F, Tisone G, Pisani F, Romagnoli J.. Transpl Int. 2015;28(Suppl 4):99.

The human pancreas as a source of protolerogenic extracellular matrix scaffold for a new generation bioartificial endocrine pancreas [abstract]. Orlando G, Peloso A, Urbani L, Cravedi P, Katari R, Maghsoudlou P, Fallas EMA, Sordi V, Purroy C, Niu GG, Mcquilling JP, Sivanandane S, Farney AC, Iskandar SS, Rogers J, Stratta RJ, Opara EC, Piemonti L, Soker S, De Coppi P.. Transpl Int. 2015;28(Suppl 4):129.

Creation and implantation of acellular rat renal ECM-based scaffolds. Peloso A, Ferrario J, Maiga B, Benzoni I, Bianco C, Citro A, Currao M, Malara A, Gaspari A, Balduini A, Abelli M, Piemonti L, Dionigi P, Orlando G, Maestri M.. Organogenesis. 2015;11(2):58-74.

Analysis of patient refusals for transplantation [abstract]. Reeves-Daniel A, Palanisamy A, Orlando G, Rogers J, Russell G, Farney A, Burkart J, Stratta R, Freedman B.. Am J Transplant. 2015;15(Suppl 3):1761.

Import pancreas transplants: good from far or far from good? [abstract]. Rogers J, Farney A, Orlando G, Reeves-Daniel A, Palanisamy A, El-Hennawy H, Khan M, Gautreaux M, Iskandar S, Stratta R.. Am J Transplant. 2015;15(Suppl 3):1068.

Novel keratin (KeraStat) and polyurethane (Nanosan-Sorb) biomaterials are hemostatic in a porcine lethal extremity hemorrhage model. Burnett LR, Richter JG, Rahmany MB, Soler R, Steen JA, Orlando G, Abouswareb T, Van Dyke ME.. J Biomater Appl. 2014;28(6):869-879.

Pancreas transplantation with portal venous drainage with an emphasis on technical aspects. Rogers J, Farney AC, Orlando G, Farooq U, Al-Shraideh Y, Stratta RJ.. Clin Transplant. 2014;28(1):16-26.

Single versus dual (en bloc) kidney transplants from donors less than 5 years of age: a single center experience [abstract]. Al-Shraideh Y, Farney A, Rogers J, Orlando G, Farooq U, Stratta R.. Am J Transplant. 2014;14(Suppl 2):72.

Is recipient BMI greater than or equal to 40 a contraindication to kidney transplantation? [abstract]. Farooq U, Alshraideh Y, Orlando G, Rogers J, Farney A, Stratta R.. Am J Transplant. 2014;14(Suppl 2):74-75.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Assistant Professor, Surgical Sciences-Transplant

Clinical Interests

Transplant Urology, Kidney Transplantation, Pancreas Transplantation, Transplant Immunology, Transplant Immunosuppression, Transplant Surgery
Giuseppe Orlando, M.D., Ph.D.

Giuseppe Orlando, M.D., Ph.D.

Assistant Professor, Surgical Sciences-Transplant

Doctor Rating

4.7 out of 5

Giuseppe Orlando, M.D., Ph.D.60 Ratings
1 Comments


 

Doctor Ratings

The overall Patient Rating score is the average of responses to the nine questions listed below. The questions are from the Press Ganey Patient Satisfaction Survey. Responses are measured on a 1 to 5 scale, where 1 represents "very poor" and 5 represents "very good."
Press Ganey Patient Satisfaction Survey

CP concern for questions/worries
4.7
CP efforts to include in decisions
4.7
CP explanations of prob/condition
4.7
CP spoke using clear language
4.7
Friendliness/courtesy of CP
4.8
Likelihood of recommending CP
4.7
Patients' confidence in CP
4.8
Time CP spent with patient
4.7
Wait time at clinic
4.2



Patient Comments

Comments are taken from the Care Provider section of the Press Ganey Patient Satisfaction Survey. Comments are posted exactly as they are written. Comments are added weekly. To protect patient privacy and confidentiality, patient names are not included.

10/12/2015

Probably the best health care team within 500 miles.

Quick Reference

Request an Appointment
New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
Magnet Hospital RecognitionConsumer Choice2015 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.